Zogenix reported $-58004000 in Net Income for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Acadia Pharmaceuticals ACAD:US $ -14.46M 29.41M
Acura Pharmaceuticals ACUR:US -387000 128K
Adamas Pharmaceuticals ADMS:US -19518000 7.17M
Aerie Pharmaceuticals AERI:US $ -39.69M 1M
Alnylam Pharmaceuticals ALNY:US $ -204.51M 14.96M
Arena Pharmaceuticals ARNA:US $ -196.31M 50.22M
AstraZeneca AZN:LN -1652M 2202M
Becton, Dickinson and BDX:US $ 265M 260M
Biocryst Pharmaceuticals BCRX:US $ -58.8M 15.6M
Biogen BIIB:US $ 329.2M 119.3M
Cardinal Health CAH:US 271M 155M
Esperion Therapeutics ESPR:US $ -69386000 25.72M
Flexion Therapeutics FLXN:US $ -30312000 8.1M
GlaxoSmithKline GSK:LN 1168M 227M
Gw Pharmaceuticals GWPH:US $ -19.68M 9.47M
Intra Cellular Therapies ITCI:US $ -76.91M 8.16M
Johnson & Johnson JNJ:US $ 3667M 2611M
Marinus Pharmaceuticals MRNS:US $ -19.51M 4.32M
Merk MRK:US $ 4567M 3022M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Neurocrine Biosciences NBIX:US $ 22.5M 19.8M
Pfizer PFE:US $ 8146M 2582M
Revance Therapeutics RVNC:US $ -74.38M 2.18M
Sarepta Therapeutics SRPT:US $ -48.14M 33.26M
Teva Pharmaceutical TEVA:IT 290M 83M
Zogenix ZGNX:US $ -58M 0.89M